Niels Nørskov-Lauritsen Selected Research

Niels Nørskov-Lauritsen Research Topics

5	Cystic Fibrosis (Mucoviscidosis) 02/2022 - 07/2013
5	Infections 03/2021 - 03/2012
1	Endocarditis 05/2024
1	Coinfection 01/2022
1	Brain Abscess (Abscess, Brain) 01/2022
1	Tuberculosis (Tuberculoses) 01/2019
1	Multiple Sclerosis 11/2017
1	Lung Diseases (Lung Disease) 05/2017
1	Intraabdominal Infections 08/2009
1	Soft Tissue Infections 08/2009

2	Anti-Infective Agents (Microbicides)IBA 02/2022 - 08/2009
2	Levofloxacin (Levaquin)FDA Link 01/2020 - 01/2019
2	Colistin (Coly-Mycin)FDA Link 01/2020 - 01/2018
2	Tigecycline (Tygacil)FDA Link 01/2019 - 08/2009
1	Bacterial DNAIBA 05/2024
1	16S Ribosomal RNAIBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2020
1	Meropenem (Merrem)FDA LinkGeneric 01/2020
1	Chloramphenicol (Chloromycetin)FDA Link 01/2020
1	Polysaccharides (Glycans)IBA 11/2019
1	FluoroquinolonesIBA 01/2019
1	TetracyclinesIBA 01/2019
1	Imipenem FDA Link 01/2019
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019
1	Doxycycline (Periostat)FDA LinkGeneric 01/2019
1	Ertapenem (Invanz)FDA Link 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Glatiramer Acetate (Copaxone)FDA Link 11/2017
1	SulfurIBA 05/2017
1	Peptide Nucleic AcidsIBA 09/2016
1	AgarIBA 07/2013
1	hexachlorocyclohexane x-factorIBA 03/2012

1	Therapeutics 01/2022
1	Central Venous Catheters 03/2021